Skip to main content

MOREPENLAB · Morepen Laboratories Limited · Financials

99.75 INR +4.75 (+5.00%) At close · Nov 13
Volume · Nov 13 609.88K Avg daily vol (14 sessions) 524.88K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
18.06B -0.3%
FY2026 Revenue FY2018–FY2026
Net Income
0
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
326.42M +1.8%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
INR 22.86B 18.06B 18.12B 16.9B 14.18B 15.47B 11.88B 8.53B 7.69B 6.07B
INR 345.48M 364.35M 289.82M 334.7M 279.3M 276.42M 302.83M 369.06M 399.03M 343.22M
INR 182.29M 164.14M 83.43M 37.1M 19.81M -73.66M 17.88M 19.85M 21.1M 43.57M
INR 613.43M 242.74M 370.94M 387.95M 170.8M 250.21M 14.22M 55.29M 3.36M 0
INR 0 0 0 0 386.75M 1.02B 970.86M 0 0 295.91M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 108.58M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.